We isolated CD16+ monocytes and NK cells from healthy individuals and B-CLL patients and performed ADCC assays using either SKBR3 cell lines or primary B-CLL cells as target cells. This evidence concerns the gene FCGR3A and B-cell chronic lymphocytic leukemia.